Camrese Lo extended-cycle and Ipratropium inhalation
Determining the interaction of Camrese Lo extended-cycle and Ipratropium inhalation and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ethinyl estradiol / levonorgestrel
Brand name: Amethia, Amethia Lo, Camrese, Camrese Lo, Daysee, Introvale, Jolessa, LoSeasonique, Quartette, Quasense, Seasonale, Seasonique, Afirmelle, Altavera, Amethyst, Ashlyna, Aubra, Aubra EQ, Aviane, Ayuna, Balcoltra, Chateal, Chateal EQ, Delyla, Enpresse-28, FaLessa, Falmina, Fayosim, Kurvelo, Larissia, Lessina, Levonest, Levora 015/30, Lillow, Lutera, Marlissa, Myzilra, Orsythia, Portia-28, Rivelsa, Setlakin, Simpesse, Sronyx, Trivora, Vienva, Alesse, Enpresse, Levlen, Levora, Lybrel, Nordette, Portia, Tri-Levlen, Triphasil-21, Triphasil-28, Trivora-28, Preven EC, Triphasil
Synonyms: Camrese Lo (extended-cycle), Camrese Lo
Generic Name: ipratropium
Brand name: Atrovent HFA, Atrovent
Synonyms: Ipratropium (Oral Inhalation)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Camrese Lo extended-cycle-Ipratropium Inhalation Aerosol
- Camrese Lo extended-cycle-Ipratropium Inhalation Solution
- Camrese Lo extended-cycle-Ipratropium Inhalation, oral/nebulization
- Camrese Lo extended-cycle-Ipratropium nasal
- Camrese Lo extended-cycle-Ipratropium Nasal 0.03
- Camrese Lo extended-cycle-Ipratropium Nasal 0.06
- Ipratropium inhalation-Canagliflozin
- Ipratropium inhalation-Canagliflozin and metformin
- Ipratropium inhalation-Canagliflozin and Metformin Extended-Release Tablets
- Ipratropium inhalation-Canagliflozin and Metformin Tablets
- Ipratropium inhalation-Canakinumab
- Ipratropium inhalation-Canakinumab Subcutaneous